Search Results - "Mirela Raos"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Bleeding risk stratification in coronary artery surgery: the should-not-bleed score by Petricevic, Mirna, Petricevic, Mate, Pasalic, Marijan, Golubic Cepulic, Branka, Raos, Mirela, Vasicek, Vesna, Goerlinger, Klaus, Rotim, Kresimir, Gasparovic, Hrvoje, Biocina, Bojan

    Published in Journal of cardiothoracic surgery (21-04-2021)
    “…An estimated 20% of allogeneic blood transfusions in the United States are associated with cardiac surgery. It is estimated that 11% of red cell resources were…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Changes in the incidence of transfusion reactions in hematological patients over the past 30years by Bojanić, Ines, Lukić, Marija, Fini Plenković, Raos, Mirela, Medenjak, Marta, Branka Golubic Ćepulić

    Published in Transfusion (Philadelphia, Pa.) (01-03-2022)
    “…BackgroundPatients with hematological diseases are polytransfused and often immunocompromised, therefore susceptible to transfusion reactions (TR). This study…”
    Get full text
    Journal Article
  4. 4

    The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia by Raos, Mirela, Lukic, Marija, Pulanic, Drazen, Vodanovic, Marijo, Cepulic, Branka Golubic

    Published in Blood transfusion = Trasfusione del sangue (01-07-2022)
    “…Autoimmune haemolytic anaemia (AIHA) is a rare autoimmune disease characterised by haemolysis associated with the presence of immunoglobulins and/or components…”
    Get full text
    Journal Article
  5. 5

    New insights in diagnostics and treatment of autoimmune haemolytic anaemia by Mirela Raos, Dražen Pulanić, Sanja Maljković, Branka Golubić Ćepulić

    Published in Liječnički vjesnik (01-03-2023)
    “…Autoimmune haemolytic anaemia is a rare disease of the immune system characterized by haemolysis of patient’s own red blood cells caused by autoantibodies…”
    Get full text
    Journal Article
  6. 6

    Susceptible and protective HLA-DR and HLA-DQ alleles for Fy a alloimmunization in the Croatian population by Raos, Mirela, Zunec, Renata, Mocibob, Marko, Gojceta, Koraljka, Lukic, Marija, Golubic Cepulic, Branka

    Published in Transfusion (Philadelphia, Pa.) (01-03-2019)
    “…Alloimmunization is a known risk of transfusion therapy caused by exposure to foreign RBC antigens. However, alloimmunization is not observed in all transfused…”
    Get full text
    Journal Article
  7. 7

    Changes in the incidence of transfusion reactions in hematological patients over the past 30 years by Bojanić, Ines, Lukić, Marija, Plenković, Fini, Raos, Mirela, Medenjak, Marta, Ćepulić, Branka Golubic

    Published in Transfusion (Philadelphia, Pa.) (01-03-2022)
    “…Background Patients with hematological diseases are polytransfused and often immunocompromised, therefore susceptible to transfusion reactions (TR). This study…”
    Get full text
    Journal Article
  8. 8

    Susceptible and protective HLA‐DR and HLA‐DQ alleles for Fya alloimmunization in the Croatian population by Raos, Mirela, Zunec, Renata, Mocibob, Marko, Gojceta, Koraljka, Lukic, Marija, Golubic Cepulic, Branka

    Published in Transfusion (Philadelphia, Pa.) (01-03-2019)
    “…BACKGROUND Alloimmunization is a known risk of transfusion therapy caused by exposure to foreign RBC antigens. However, alloimmunization is not observed in all…”
    Get full text
    Journal Article
  9. 9

    Guidelines of the Croatian Society for Transfusion Medicine for determination of Rh (D) blood group and application of RhD genotyping by Zrinka Kruhonja Galić, Mirela Raos, Bojana Bošnjak, Slavica Dajak, Linda Caser, Jasna Bingulac-Popović, Ana Hećimović, Sandra Jagnjić, Vesna Đogić, Irena Jukić

    Published in Liječnički vjesnik (06-06-2022)
    “…The working group of the Croatian Society for Transfusion Medicine has prepared guidelines for the determination of Rh (D) blood group and the application of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Smjernice Hrvatskog društva za transfuzijsku medicinu za određivanje Rh(D) krvne grupe i primjenu RhD genotipizacije by Kruhonja Galić, Zrinka, Raos, Mirela, Bošnjak, Bojana, Dajak, Slavica, Caser, Linda, Bingulac-Popović, Jasna, Hećimović, Ana, Jagnjić, Sandra, Đogić, Vesna, Jukić, Irena

    Published in Liječnički vjesnik (06-06-2022)
    “…SAŽETAK Radna skupina Hrvatskog društva za transfuzijsku medicinu pripremila je smjernice za određivanje Rh(D) krvne grupe i primjenu RhD genotipizacije. U…”
    Get full text
    Journal Article
  12. 12

    Prijetransfuzijsko ispitivanje i transfuzijsko liječenje pri primjeni monoklonskog protutijela anti-CD38 by Raos, Mirela, Bojanić, Ines, Bašić Kinda, Sandra, Batinić, Josip, Golubić Ćepulić, Branka

    Published in Liječnički vjesnik (02-02-2021)
    “…Daratumumab je prvo monoklonsko protutijelo anti-CD38 koje se primjenjuje u liječenju multiplog mijeloma. Njegova primjena uzrokuje panreaktivnost u testovima…”
    Get full text
    Paper
  13. 13